40% Patients Suffer Relapse Within 18 Months ...

An international research team has succeeded in elucidating key immunological and biochemical mechanisms underlying ...

TheFly reported that QNCX presented Phase 2a clinical results for LAM-001 on May 18, at the American Thoracic Society ...

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) ...

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less ...

Seven years of exhaustion, blamed on motherhood. Catherine Wanjiru almost died of heart block. A pacemaker saved her. But in ...

Hoffmann won a $50,000 research grant to search for a cure to Facioscapulohumeral Muscular Dystrophy, or FSHD, a disease she ...

Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be ...

The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

A medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research. The experimental drug, taken once a day, extends patients’ lives by slowing the ...